Randomized phase 2 trial of NP001, a novel immune regulator
Safety and early efficacy in ALS
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 24, 2014
- Accepted in final form February 20, 2015
- First Published April 9, 2015.
Author Disclosures
- Robert G. Miller, MD,
- Gilbert Block, MD, PhD,
- Jonathan S. Katz, MD,
- Richard J. Barohn, MD,
- Vidhya Gopalakrishnan, PhD,
- Merit Cudkowicz, MD,
- Jane R. Zhang, BS,
- Michael S. McGrath, MD, PhD,
- Elizabeth Ludington, PhD,
- Stan H. Appel, MD and
- Ari Azhir, PhD
- Robert G. Miller, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gilbert Block, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jonathan S. Katz, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Richard J. Barohn, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Vidhya Gopalakrishnan, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Merit Cudkowicz, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jane R. Zhang, BS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michael S. McGrath, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Elizabeth Ludington, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stan H. Appel, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ari Azhir, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the California Pacific Medical Center (R.G.M., J.S.K.), San Francisco, CA; Neuraltus Pharmaceuticals, Inc. (G.B., V.G., M.S.M., A.A.), Palo Alto, CA; University of Kansas (R.J.B.), Kansas City; Massachusetts General Hospital (M.C.), Boston; University of California, San Francisco (R.Z., M.S.M.); Agility Clinical, Inc. (E.L.), Carlsbad, CA; and The Methodist Hospital (S.H.A.), Houston, TX.
- Correspondence to Dr. Miller: millerrx{at}sutterhealth.org
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosisExamining a more efficient trial designR.G. Miller, D.H. Moore, D.A. Forshew et al.Neurology, August 03, 2011 -
Article
Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosisBenjamin J. Murdock, Diane E. Bender, Samy R. Kashlan et al.Neurology: Neuroimmunology & Neuroinflammation, June 01, 2016 -
Articles
Lithium carbonate in amyotrophic lateral sclerosisLack of efficacy in a dose-finding trialA. Chiò, G. Borghero, A. Calvo et al.Neurology, August 11, 2010 -
Articles
Effect of recombinant human insulin-like growth factor-I on progression of ALSA placebo-controlled studyE. C. Lai, K. J. Felice, B. W. Festoff et al.Neurology, December 01, 1997